Theracryf Plc (AIM:TCF)
0.2340
-0.0210 (-8.24%)
Jun 18, 2025, 9:44 AM GMT+1
Theracryf Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 2.11 | 2 | 5 | 4.51 | 5.59 | Upgrade
|
Short-Term Investments | 2.01 | - | - | 4.52 | 6 | Upgrade
|
Cash & Short-Term Investments | 4.11 | 2 | 5 | 9.03 | 11.59 | Upgrade
|
Cash Growth | 105.29% | -59.92% | -44.63% | -22.11% | 180.63% | Upgrade
|
Accounts Receivable | 0.51 | - | - | - | - | Upgrade
|
Other Receivables | 0.54 | 0.97 | 1.02 | 0.48 | 0.65 | Upgrade
|
Receivables | 1.06 | 0.97 | 1.02 | 0.48 | 0.65 | Upgrade
|
Prepaid Expenses | - | 0.05 | 0.11 | 0.07 | 0.1 | Upgrade
|
Total Current Assets | 5.17 | 3.03 | 6.13 | 9.58 | 12.35 | Upgrade
|
Property, Plant & Equipment | - | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Other Intangible Assets | 2.46 | 0.03 | 0.04 | 0.05 | 0.07 | Upgrade
|
Other Long-Term Assets | - | -0 | - | - | - | Upgrade
|
Total Assets | 7.63 | 3.06 | 6.17 | 9.64 | 12.42 | Upgrade
|
Accounts Payable | 1.66 | 0.33 | 0.4 | 0.07 | 0.41 | Upgrade
|
Accrued Expenses | - | 0.32 | 0.39 | 0.32 | 0.17 | Upgrade
|
Current Income Taxes Payable | - | 0.03 | 0.03 | 0.02 | 0.03 | Upgrade
|
Other Current Liabilities | - | 0.05 | 0.01 | 0 | 0 | Upgrade
|
Total Current Liabilities | 1.66 | 0.72 | 0.83 | 0.41 | 0.61 | Upgrade
|
Other Long-Term Liabilities | -0 | -0 | - | - | - | Upgrade
|
Total Liabilities | 1.66 | 0.72 | 0.83 | 0.41 | 0.61 | Upgrade
|
Common Stock | 5.32 | 0.69 | 0.69 | 0.69 | 0.69 | Upgrade
|
Additional Paid-In Capital | 28.7 | 27.87 | 27.87 | 27.87 | 27.87 | Upgrade
|
Retained Earnings | -30.43 | -28.92 | -25.79 | -21.89 | -19.17 | Upgrade
|
Comprehensive Income & Other | 2.38 | 2.7 | 2.58 | 2.56 | 2.43 | Upgrade
|
Shareholders' Equity | 5.97 | 2.34 | 5.34 | 9.23 | 11.81 | Upgrade
|
Total Liabilities & Equity | 7.63 | 3.06 | 6.17 | 9.64 | 12.42 | Upgrade
|
Net Cash (Debt) | 4.11 | 2 | 5 | 9.03 | 11.59 | Upgrade
|
Net Cash Growth | 105.29% | -59.92% | -44.63% | -22.11% | 180.63% | Upgrade
|
Net Cash Per Share | 0.01 | 0.01 | 0.02 | 0.03 | 0.08 | Upgrade
|
Filing Date Shares Outstanding | 2,130 | 274.89 | 274.89 | 274.89 | 274.89 | Upgrade
|
Total Common Shares Outstanding | 2,130 | 274.89 | 274.89 | 274.89 | 274.89 | Upgrade
|
Working Capital | 3.51 | 2.31 | 5.3 | 9.17 | 11.74 | Upgrade
|
Book Value Per Share | 0.00 | 0.01 | 0.02 | 0.03 | 0.04 | Upgrade
|
Tangible Book Value | 3.51 | 2.31 | 5.3 | 9.17 | 11.75 | Upgrade
|
Tangible Book Value Per Share | 0.00 | 0.01 | 0.02 | 0.03 | 0.04 | Upgrade
|
Machinery | - | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.